Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Freshpet (FRPT)

Freshpet 2024 net income $46.9 million, up from a loss; Q4 net sales rise 22% to $262.7 million

Positive Impact 4 of 5 earnings Written later

Freshpet reported fourth-quarter and full-year 2024 results, with net sales up 22.0% in the quarter and 27.2% for the year, and full-year net income of $46.9 million compared with a net loss of $33.6 million in 2023. The company guided 2025 net sales of $1.18 billion to $1.21 billion and Adjusted EBITDA of at least $210 million, and raised its 2027 Adjusted Gross Margin and Adjusted EBITDA margin targets.

Key points

  • Q4 2024 net sales were $262.7 million, up 22.0%, and net income was $18.1 million versus $15.3 million a year earlier.
  • Full-year 2024 Adjusted EBITDA was $161.8 million, compared with $66.6 million in 2023.
  • 2025 guidance: net sales of $1.18 billion to $1.21 billion (up 21% to 24%) and Adjusted EBITDA of at least $210 million.
  • 2027 targets: Adjusted Gross Margin raised to 48% from 45%, and Adjusted EBITDA margin raised to 22% from 18%; net sales target of $1.8 billion unchanged.

The filing

CompanyFreshpet (FRPT)
Form8-K, current report
Filed with the SECFeb 20, 2025, 6:25 AM ET
Accession number0001611647-25-000005

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 20, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.